Rising Need for Sleep Apnea Diagnostic and Therapeutic Devices Fueling Growth

The global sleep apnea diagnostic and therapeutic devices market for set to reach US$6,437.6 million by 2019 from an estimated value of US$3,805.3 million in 2012. The market is rapidly growing at a CAGR of 7.8% from 2013 to 2019, states Transparency Market Research in its new report titled ‘Sleep Apnea Diagnostic and Therapeutic Devices Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019’.

Sleep apnea devices industry is witnessing a rapid pace of technological advances that result in the development of effective diagnostic and therapeutic platforms. Sleep disorders hamper the quality of life and result in loss of productivity of an individual. Many of the sleep apnea cases are undiagnosed due to lack of awareness regarding the symptoms and effects. Untreated sleep apnea results in worsening of several health conditions such as hypertension, stroke, diabetes, heart diseases and others. Hence, diagnosis of sleep apnea is essential to maintain a healthy and productive lifestyle. Sleep studies are the most crucial diagnostic measure employed to confirm sleep apnea.

Browse Full Press Release: http://www.transparencymarketresearch.com/pressrelease/sleep-apnea-devices-market.htm

Post diagnosis based on the severity of the condition the patient is recommended to use several therapeutic devices such as oral appliances, positive airway pressure devices, oxygen concentrator etc. Home sleep testing and sleep laboratory testing represents the two modes of diagnosis. Currently, home sleep testing with its compact and user friendly devices are preferred over the conventional equipment. This is majorly due to high comfort levels and ease of handling of these devices. The major factors contributing towards proliferation of sleep apnea devices market are persistent product modifications, introduction of novel technologies and increasing awareness of sleep apnea. On the contrary high cost of diagnostic procedures, lack of patient compliance with therapeutic devices and high degree of discomfort levels are some of the factors that might encumber the growth of sleep apnea devices market. The global market for sleep apnea devices market was valued at USD 3,805.3 million in 2012 and is estimated to reach USD 6,437.6 million by 2019 growing at a CAGR of 7.8% from 2013 to 2019.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=588

Sleep apnea devices market can be analyzed by diagnostic and therapeutic devices and geography. Diagnostic devices segment is further classified into four major types. Actigraphy devices are anticipated to grow at a highest CAGR of over 7% followed by respiratory polygraph throughout the forecast period from 2013 to 2019. The major reason being the compact nature of these devices and these devices support home testing with high reliability. In addition, rapid pace of technological advances and increased preference for portable and mobile devices further fuel the growth of the market. This can be evident from some of the technologically advanced development of efficient and compatible actigraphy systems along with development of various forms of pulse oximeters.

Innovation and novelty in design and features of therapeutic devices provide lucrative growth prospects for the sleep apnea devices market. This can be evident from the introduction of implantable devices based on neurostimulation along with development of portable and highly mobile treatment devices such as CPAP device developed by Human Design Medical Company. All these factors encourage the growth and uptake of these devices worldwide. Positive airway pressure (PAP) devices and oral appliances are estimated to record highest growth rates during the forecast period. The major reason being the development of custom made devices depending on the nature of symptoms and patient compliance.

The overall ophthalmology devices market is highly fragmented with the presence of both established and emerging companies in this field which includes ResMed, Inc., Philips Healthcare (Respironics), CareFusion Corporation, Fisher & Paykel Healthcare and GE Healthcare. Rigorous investments by the companies towards developing efficient diagnostic and therapeutic platforms is evident for promising growth prospects in this market. The factors that influence the proliferation of the market are perennial product amendments followed by increasing number of sleep apnea patients across the globe. However, lack of patient compliance, less favorable reimbursement scenario and high costs of the diagnostic procedures might impede the market growth.

Browse the full Sleep Apnea Diagnostic and Therapeutic Devices Market (Actigraphy, Polysomnography (PSG) systems, Positive Airway Pressure (PAP) Devices, Oral Appliances and Others) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019 report at http://www.transparencymarketresearch.com/sleep-apnea-devices-market.html

The global sleep apnea devices market is segmented into the following categories:

Sleep Apnea Diagnostic and Therapeutic Devices Market, by Diagnostic Devices

• Actigraphy Systems
• Polysomnography (PSG) Device
• Respiratory polygraph
• Single-Channel Screening Devices (pulse Oximeters)

Sleep Apnea Diagnostic and Therapeutic Devices Market, by Therapeutic Devices

• Airway Clearance Systems
• Adaptive Servo-Ventilation (ASV)
• Positive Airway Pressure (PAP) Device
• Oral Appliances
• Oxygen Devices
• Others

Sleep Apnea Diagnostic and Therapeutic Devices Market, by Geography

• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)